Intelligent Bio Solutions Stock Number Of Shares Shorted
| INBS Stock | USD 1.46 0.02 1.35% |
Fundamental analysis of Intelligent Bio allows traders to better anticipate movements in Intelligent Bio's stock price by examining its financial health and performance throughout various phases of its business cycle.
Intelligent | Number Of Shares Shorted | Build AI portfolio with Intelligent Stock |
Intelligent Bio Solutions Company Number Of Shares Shorted Analysis
Intelligent Bio's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Intelligent Bio Number Of Shares Shorted | 537.78 K |
Most of Intelligent Bio's fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Intelligent Bio Solutions is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Intelligent Number Of Shares Shorted Driver Correlations
Understanding the fundamental principles of building solid financial models for Intelligent Bio is extremely important. It helps to project a fair market value of Intelligent Stock properly, considering its historical fundamentals such as Number Of Shares Shorted. Since Intelligent Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Intelligent Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Intelligent Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, Intelligent Bio Solutions has 537.78 K of outstending shares currently sold short by investors. This is 83.19% lower than that of the Health Care Equipment & Supplies sector and 82.05% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 88.57% higher than that of the company.
Intelligent Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Intelligent Bio's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Intelligent Bio could also be used in its relative valuation, which is a method of valuing Intelligent Bio by comparing valuation metrics of similar companies.Intelligent Bio is currently under evaluation in number of shares shorted category among its peers.
Intelligent Bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Intelligent Bio from analyzing Intelligent Bio's financial statements. These drivers represent accounts that assess Intelligent Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Intelligent Bio's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 53.5M | 9.7M | 475.4K | 787.9K | 2.5M | 2.4M | |
| Enterprise Value | 40.9M | 1.5M | 273.8K | (4.6M) | 1.8M | 1.7M |
Intelligent Fundamentals
| Return On Equity | -1.93 | ||||
| Return On Asset | -0.59 | ||||
| Operating Margin | (3.41) % | ||||
| Current Valuation | 12.46 M | ||||
| Shares Outstanding | 8.98 M | ||||
| Shares Owned By Insiders | 1.05 % | ||||
| Shares Owned By Institutions | 7.98 % | ||||
| Number Of Shares Shorted | 537.78 K | ||||
| Price To Book | 4.41 X | ||||
| Price To Sales | 4.32 X | ||||
| Revenue | 3.05 M | ||||
| Gross Profit | 1.25 M | ||||
| EBITDA | (9.34 M) | ||||
| Net Income | (10.57 M) | ||||
| Cash And Equivalents | 8.28 M | ||||
| Cash Per Share | 0.56 X | ||||
| Total Debt | 281.81 K | ||||
| Current Ratio | 2.33 X | ||||
| Book Value Per Share | 0.41 X | ||||
| Cash Flow From Operations | (9.68 M) | ||||
| Short Ratio | 2.12 X | ||||
| Earnings Per Share | (2.00) X | ||||
| Target Price | 12.0 | ||||
| Number Of Employees | 53 | ||||
| Beta | 4.59 | ||||
| Market Capitalization | 13.2 M | ||||
| Total Asset | 8.25 M | ||||
| Retained Earnings | (62.53 M) | ||||
| Working Capital | (1.21 M) | ||||
| Net Asset | 8.25 M |
About Intelligent Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Intelligent Bio Solutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intelligent Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intelligent Bio Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Intelligent Stock Analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.